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Abstract 
 
Background/Purpose: Oxidative stress is implicated in the pathogenesis of 
necrotizing enterocolitis (NEC). Hydrogen sulfide (H2S) has been reported to have a 
protective function against oxidative stress in the gut. We hypothesize that 
administration of H2S can help decrease intestinal epithelial cell injury in vitro. 
Methods: Intestinal epithelial cells (IEC-18) were treated with 200µM hydrogen 
peroxide (H2O2) for 21 hours. At 21 hours sodium hydrosulfide (NaHS), a H2S donor, 
was administered as a rescue treatment at two different concentrations: 0.1 mM and 
0.2 mM. At 24 hours, cell viability was measured using a colorimetric assay (MTT). 
Oxidative stress was studied by glutathione peroxidase (GPx) activity and 
thiobarbituric acid reactive substances (TBARS). IL-6 and TNFα levels were tested to 
study inflammation. Data were presented as mean±SD and compared using one-way 
ANOVA with Bonferroni post-test. 
Results: Compared to control, H2O2-treated IEC-18 had reduced viability (p<0.01), 
lower GPx activity (p<0.01), higher TBARS levels (p<0.01), and increased IL6 and 
TNFα (p<0.001). Compared to H2O2-treated IEC-18, treatment with 0.2mM NaHS 
rescued viability (p<0.01), increased GPx activity (p<0.05), and reduced TBARS 
(p<0.01), IL6 and TNFα (p<0.001).  
Conclusions: H2S successfully rescues epithelial cell damage induced by oxidative 
stress in vitro. This indicates that H2S could be a potential pharmacological 
intervention in conditions like NEC. 
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Introduction 
In premature infants, oxidative stress is considered one of the primary mechanisms 
involved in the pathogenesis of diseases such as retinopathy of prematurity, chronic 
lung disease, and necrotizing enterocolitis (NEC) [1]. These patients have low-
efficient antioxidant systems that fail to counteract the harmful effects of oxidative 
stress-generated reactive oxygen species (ROS). A direct link between ROS 
production in the premature gut and NEC development has been suggested [2-4]. 
There is experimental evidence that NEC evolves from disruption of the intestinal 
epithelial barrier, due to production of reactive nitrogen derivatives such as 
peroxynitrite that induce enterocyte apoptosis, necrosis and damage the tight and gap 
junctions, thus altering gut permeability [5]. The exaggerated inflammatory response 
leads to upregulation of the inducible form of nitric oxide synthase (iNOS) within the 
mucosa. As a result, some investigators have proposed treatment strategies that are 
aimed at abrogating iNOS production [6]. Ciftci et al demonstrated that 
administration of aminoguanidine, which is an inhibitor of iNOS, decreased tissue 
levels of reactive nitrogen species and improves intestinal inflammatory damage in a 
neonatal rat model of NEC [7]. Similarly, Zuckerbraun et al showed that exposure to 
carbon monoxide both in vitro (enterocyte cell line) and in vivo (neonatal rat model) 
resulted in decreased iNOS production, reduced serum levels of pro-inflammatory 
cytokines, and decreased apoptosis rate [8]. Moreover, human studies have shown that 
formula supplementation with L-Arginine, a nitric oxide donor, could be beneficial in 
preventing NEC development in preterm infants [9,10], although the data are not 
sufficient to support a practice recommendation [11,12]. 
In search for novel treatment agents that could offset oxidative stress induced bowel 
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damage in preterm infants with NEC, we focused on hydrogen sulfide (H2S). H2S is 
an endogenously produced gaseous mediator which is a key regulator in physiological 
and pathological processes in various systems including the gastrointestinal tract [13-
17]. H2S has an anti-inflammatory and cytoprotective function, and contributes to 
mucosal defense against infection in the gastrointestinal tract [18]. Its protective role 
has been confirmed by studies in models of experimental colitis showing that on the 
one hand inhibition of H2S synthesis leads to mucosal inflammation, increased 
susceptibility to injury, and impaired healing and on the other hand administration of 
H2S donors accelerate healing and exert significant anti-inflammatory effects [19-22].  
In the present study, we aimed to investigate whether H2S could be beneficial against 
intestinal epithelium injury induced by oxidative stress using an intestinal epithelial 
cell line. 
 
 
Methods 
Cells and study groups 
A rat small intestinal epithelial cell line, IEC-18, was purchased from the American 
Type Culture Collection (ATCC, Manassas, VA) and maintained in Dulbecco’s 
modified Eagle’s medium with high glucose (DMEM, Gibco BRL) supplemented 
with 10% fetal bovine serum (FBS, GibcoBRL) and 100 mg/ml penicillin and 
streptomycin (Sigma-Aldrich). Cells were cultured at 37°C in a humidified 
atmosphere with 5% CO2.  
For all experiments presented herein, there were four study groups:  
5 
 
i. Control – IEC-18 were exposed to medium alone as control  
ii. H2O2 - IEC-18 were treated with 200µM hydrogen peroxide (H2O2) for 21 
hours to mimic intestinal epithelial injury.  
iii. NaHS low concentration – IEC-18 were treated with 200µM H2O2 for 21 
hours and NaHS 0.1mM was added for additional 3 hours (total 24 hour 
experiment) 
iv. NaHS high concentration – IEC-18 were treated with 200µM H2O2 for 21 
hours and NaHS 0.2mM was added for additional 3 hours (total 24 hours) 
Cell viability  
IEC-18 cell viability was tested using a colorimetric assay that detects the conversion 
of MTT into formazan by the mitochondrial enzyme succinate dehydrogenase. After 
treatment, 0.5 mg/ml MTT (ATCC, Manassas, VA) was added to the medium for 3 
hour incubation, the insoluble formazan crystals within the cells were extracted by 
DMSO, and the absorbance was measured using a micro-plate reader (Molecular 
Devices SpectraMax Gemini EM) at a wavelength of 570 nm.  
Oxidative stress  
To investigate the effects of oxidative stress induced by H2O2, we measured 
glutathione peroxidase (GPx) activity and thiobarbituric acid reactive substances 
(TBARS) in IEC-18 cells. Both were normalized to protein, measured by BCA 
protein assay kit (Thermo Scientific, USA). GPX activity in cell lysate was measured 
using a commercial test kit (Cayman Chemical Company, Michigan) according to the 
manufacturer’s instructions. Briefly, GPx catalyzed the oxidation of glutathione (GSH) 
by hydroperoxide. In the presence of glutathione reductase and NAPDH, the oxidized 
glutathione is immediately converted to the reduced form with a concomitant 
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oxidation of NAPDH to NAPD+. The decreased in absorbance at 340nm was 
measured by a micro-plate reader (Molecular Devices SpectraMax Gemini EM). The 
specific activity for GPx was expressed in units per milligram protein (U/mg protein). 
TBARS were measured in the cell lysate (Cayman Chemical Company, Michigan). 
Briefly, tricholoroacetic in sodium sulfate was added into cell lysates.  After 
precipitation, the samples were washed by sulfuric acid and then incubated in a 
boiling water bath for one hour. After cooling, the samples were extracted with n-
butanol and centrifuged for 10 minutes at 1600 x g at 4°C. Absorbance was measured 
using a micro-plate reader (Molecular Devices SpectraMax Gemini EM) at a 
wavelength of 540 nm. 
Inflammation 
To study the effects of NaHS on inflammation, pro-inflammatory cytokines IL-6 and 
TNFα levels were measured in the cell supernatant using ELISA (IL-6: Sigma, MO, 
USA; TNFα: Thermo Scientific, USA). Absorbance was measured using a micro-
plate reader (Molecular Devices SpectraMax Gemini EM) at a wavelength of 450 
nm.  
Statistics 
Results are presented as mean ± SD according to normality of data distribution 
(Kolmogorov-Smirnov test). Data were compared using one-way ANOVA with 
Bonferroni post-test. P<0.05 was considered significant. 
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Results 
Cell viability  
Cells treated with H2O2 had decreased viability compared to control (0.29±0.04 vs. 
0.44±0.03, p<0.01; Figure 1). Cell viability was not increased by the addition of 
0.1mM NaHS (0.34±0.05, p= n.s. to control), but it was rescued by 0.2mM NaHS 
(0.42±0.09; p<0.01 to H2O2; p= n.s. to control; Figure 1).  
Oxidative stress  
Treatment with H2O2 significantly decreased GPx activity in comparison to control 
(65.6±27.6 U/mg vs. 139.6±46.1U/mg, p<0.01; Figure 2A). GPx activity was not 
significantly improved by 0.1mM NaHS treatment (122.8±9.8U/mg, p= n.s. to H2O2; 
Figure 2A), but was rescued by 0.2mM NaHS (136.6±29.5U/mg; p<0.01 to H2O2; p= 
n.s. to control; Figure 2A). TBARS levels were significantly increased in H2O2 
treated cells compared to control (0.57±0.1µM MDA equivalents vs. 0.2±0.2µM, 
p<0.01; Figure 2B). Treatment with 0.1mM NaHS did not decrease TBARS levels 
(0.37±0.06µM, p= n.s. to H2O2; Figure 2B), which were instead significantly reduced 
by 0.2mM NaHS treatment (0.11±0.09µM, p<0.001 to H2O2; p=ns to control; Figure 
2B). 
Inflammation  
H2O2 significantly increased supernatant IL-6 levels compared to control 
(2537±367pg/ml vs. 198±62pg/ml, p<0.01; Figure 3A). Conversely, compared with 
H2O2 both 0.1mM NaHS and 0.2mM NaHS treatments decreased IL-6 levels (0.1mM 
NaHS: 1593±130pg/ml, p<0.01 to H2O2; 0.2mM NaHS: 820±83pg/ml, p<0.001 to 
H2O2; Figure 3A). Similarly, TNFα levels were increased in H2O2 compared to 
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control (2537±367pg/ml vs. 198±62pg/ml; p<0.01; Figure 3B), and were 
significantly decreased by both 0.1mM NaHS and 0.2mM NaHS compared to H2O2 
(0.1mM NaHS: 1593±130pg/ml, p<0.01 to H2O2; 0.2mM NaHS: 820±83pg/ml, 
p<0.001 to H2O2; Figure 3B). 
 
 
Discussion 
The present study indicates that H2S has the potential of rescuing the intestinal 
epithelial cell damage induced by oxidative stress.  
Epithelial damage was successfully modelled in vitro using H2O2, as verified by the 
effects on cell viability. This is a well-established model of epithelial injury induced 
by oxidative stress and it relies on the evidence that ROS, particularly H2O2, cause 
epithelial permeability changes and mucosal injury in small intestinal cell lines [23-
24]. In our experiments, the epithelial damage induced by H2O2 was rescued when the 
cells were treated with a higher concentration of NaHS that significantly improved 
cell viability. This is in line with other studies that have shown how H2S donors such 
as NaHS may have a protective effect on the intestinal mucosa [25-28]. The 
mechanism through which NaHS is protective against oxidative stress-induced 
intestinal injury can be related to the attenuation of ROS level and inflammation. 
To investigate the effects of oxidative stress induced by H2O2, we measured 
glutathione peroxidase activity and TBARS in IEC-18 cells and found that NaHS 
treatment at a higher concentration acted effectively as anti-oxidant. Glutathione 
peroxidase function is to reduce lipid hydroperoxides to their corresponding alcohols 
and to reduce free H2O2 to water. Several studies have reported the same effect in the 
intestine. Liu et al demonstrated that NaHS treatment in a model of intestinal 
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ischemia/reperfusion injury could significantly reduce the severity of bowel damage 
by increasing glutathione peroxidase activity in both serum and intestinal tissue [29]. 
A similar effect was reported by Henderson et al, who were able to attenuate 
ischemia/reperfusion small bowel injury both in vitro and in vivo via administration of 
NaHS after the onset of ischemia [30].  
We also investigated TBARS amount and found that this was significantly increased 
when IEC-18 were exposed to H2O2 and recovered when higher concentrations of 
NaHS were employed. TBARS are end products of lipid peroxidation, which refers to 
the oxidative degradation of lipids. In this process, ROS steal electrons from the lipids 
in cell membranes, resulting in cell damage.  
Finally we investigated whether the H2O2 induced intestinal epithelial damage 
resulted in release of inflammatory cytokines and whether this phenomenon was 
reversed by administration of NaHS. In the present study both concentrations of 
NaHS reduced IL-6 and TNF-α levels in IEC-18 supernatant. H2S has been reported 
to be a modulator of inflammatory processes in various systems, including the 
gastrointestinal tract. In animal models of inflammation and inflammation-related 
pain, H2S has proven to exert protective effects by reducing edema formation via 
effects on KATP channels [31]. Moreover, it has been shown that H2S donors are able 
to inhibit leukocyte infiltration and that inhibition of H2S synthesis promotes 
leukocyte infiltration [31].  
H2S seems to be protective against oxidative stress and inflammation, which are 
pathological processes that typically affect a preterm intestine. These beneficial 
effects of H2S on a small intestinal cell line represent a proof of concept for a 
promising novel treatment in a neonatal intestinal disease such as NEC. Theoretically, 
H2S could be useful in the initial stages of NEC, i.e. Bell stage 1 or 2, before the 
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intestinal inflammatory process is so advanced that surgery would be required. 
However, to translate this observation into clinical practice, further studies are needed 
to confirm the present findings in an in vivo model of NEC.  
In conclusion, in this in vitro study we have demonstrated that intestinal cell viability 
is impaired by exposure to H2O2, which mimics the oxidative stress on the intestinal 
epithelium. This damage can be reversed by treatment with NaHS, an H2S donor that 
prevents oxidative damage and acts an anti-inflammatory agent. These findings 
indicate the potential for a pharmacological intervention to rescue the intestinal 
epithelium in intestinal pathological conditions such as NEC.  
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Figure legends 
 
Figure 1: IEC-18 viability measured by MTT assay.  
 
Figure 2: Oxidative stress - A) Glutathione peroxidase (GPx) activity of IEC-18 
measured by GPx Assay kit. B) Thiobarbituric acid reactive substances (TBARS) 
levels of IEC-18 measured by TBARS Assay kit.  
 
Figure 3: Inflammation – A) IL-6 levels from IEC-18 cell supernatant. B) TNFα 
levels from IEC-18 cell supernatant. 
 
 
 
 
 
  
17 
 
  
18 
 
Figure 1 
 
 
  
co
nt
ro
l
H 2
O 2
 2
00
mM
H 2
O 2
 +
 N
aH
S 
0.
1m
M
H 2
O 2
 +
 N
aH
S 
0.
2m
M
0.0
0.2
0.4
0.6
p<0.01
p<0.01
p= ns
p= ns
C
e
ll 
V
ia
b
ili
ty
 (
O
D
 5
7
0
n
m
)
19 
 
Figure 2 
 
A 
 
 
B 
 
  
co
nt
ro
l
H 2
O 2
 2
00
m
M
H 2
O 2
 +
 N
aH
S 
0.
1m
M
H 2
O 2
 +
 N
aH
S 
0.
2m
M
0
50
100
150
200
p<0.05
p<0.05
p= ns
p= ns
G
P
x
 A
c
ti
v
it
y
 (
m
U
/m
g
 p
ro
te
in
)
co
nt
ro
l
H 2
O 2
 2
00
m
M
H 2
O 2
 +
 N
aH
S 
0.
1m
M
H 2
O 2
 +
 N
aH
S 
0.
2m
M
0.0
0.2
0.4
0.6
0.8
p<0.01
p= ns
p<0.001
p= ns
M
D
A
 (
m
M
)
20 
 
Figure 3 
 
A 
 
 
 
B 
 
C
on
tr
ol
H 2
O 2
 2
00
mM
H 2
O 2
 +
 N
aH
S 
0.
1m
M
H 2
O 2
 +
 N
aH
S 
0.
2m
M
0
1000
2000
3000
p<0.001
p<0.001
p<0.001
p<0.001
IL
6
 (
p
g
/m
l)
C
on
tr
ol
H 2
O 2
 2
00
mM
H 2
O 2
 +
 N
aH
S 
0.
1m
M
H 2
O 2
 +
 N
aH
S 
0.
2m
M
0
500
1000
1500
2000
p<0.001
p<0.001
p<0.001
p= ns
T
N
F
a
 (
p
g
/m
l)
